The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Endocarditis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Endocarditis

 

Psychiatry related information on Endocarditis

 

High impact information on Endocarditis

 

Chemical compound and disease context of Endocarditis

 

Biological context of Endocarditis

 

Anatomical context of Endocarditis

 

Gene context of Endocarditis

  • TIMP2 mRNA was found in three cases of endocarditis [27].
  • Signals for MMP9 mRNA were found in two cases with endocarditis and five cases with degenerative valvular disease [27].
  • Synthesis of MMP2 mRNA was found in seven valves, five with endocarditis and two with degenerative valvular disease [27].
  • TIMP1 mRNA, on the other hand, was found in 17 cases, both endocarditis and degenerative valvular disease [27].
  • Persistent TNF amounts were associated with the occurrence of endocarditis in patients with valvulopathy, and that may be a marker of chronic evolution of Q fever [28].
 

Analytical, diagnostic and therapeutic context of Endocarditis

References

  1. Ciprofloxacin in a case of Q fever endocarditis. Yebra, M., Ortigosa, J., Albarrán, F., Crespo, M.G. N. Engl. J. Med. (1990) [Pubmed]
  2. Cefazolin and Staphylococcus aureus endocarditis. Kaye, D., Hewitt, W., Remington, J.S., Turck, M. JAMA (1977) [Pubmed]
  3. Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime. Hyams, K.C., Mader, J.T., Pollard, R.B., Parks, D.H., Thomson, P.D., Reinarz, J.A. JAMA (1981) [Pubmed]
  4. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. Morris, C.D., Reller, M.D., Menashe, V.D. JAMA (1998) [Pubmed]
  5. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Levine, D.P., Fromm, B.S., Reddy, B.R. Ann. Intern. Med. (1991) [Pubmed]
  6. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia. Nolan, C.M., Abernathy, R.S. Arch. Intern. Med. (1977) [Pubmed]
  7. Indications for cardiac surgery in patients with active infective endocarditis. Alsip, S.G., Blackstone, E.H., Kirklin, J.W., Cobbs, C.G. Am. J. Med. (1985) [Pubmed]
  8. Intravenous drug addiction--staphylococcal septicemia--pulmonary embolism: a triad pathognomonic for tricuspid valve endocarditis? Julander, I., Arneborn, P., Bäck, E., Höglund, C., Svanbom, M. Scand. J. Infect. Dis. (1983) [Pubmed]
  9. Gentamicin-resistant enterococcal endocarditis: the need for routine screening for high-level resistance to aminoglycosides. Libertin, C.R., McKinley, K.M. South. Med. J. (1990) [Pubmed]
  10. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. Daniel, W.G., Mügge, A., Martin, R.P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., Lichtlen, P.R. N. Engl. J. Med. (1991) [Pubmed]
  11. JAMA patient page. Endocarditis. Stevens, L.M. JAMA (2002) [Pubmed]
  12. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. Francioli, P., Etienne, J., Hoigné, R., Thys, J.P., Gerber, A. JAMA (1992) [Pubmed]
  13. Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. Wilson, W.R. JAMA (1992) [Pubmed]
  14. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. Wilson, W.R., Thompson, R.L., Wilkowske, C.J., Washington, J.A., Giuliani, E.R., Geraci, J.E. JAMA (1981) [Pubmed]
  15. Clindamycin in infective endocarditis. Cherubin, C.E., Nair, S.R. JAMA (1978) [Pubmed]
  16. Single-antibiotic therapy for streptococcal endocarditis. Karchmer, A.W., Moellering, R.C., Maki, D.G., Swartz, M.N. JAMA (1979) [Pubmed]
  17. Unsuccessful treatment of staphylococcal endocarditis with cefazolin. Bryant, R.E., Alford, R.H. JAMA (1977) [Pubmed]
  18. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis. Gavaldà, J., López, P., Martín, T., Gomis, X., Ramírez, J.L., Azuaje, C., Almirante, B., Pahissa, A. Antimicrob. Agents Chemother. (2002) [Pubmed]
  19. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. Shiro, H., Muller, E., Gutierrez, N., Boisot, S., Grout, M., Tosteson, T.D., Goldmann, D., Pier, G.B. J. Infect. Dis. (1994) [Pubmed]
  20. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Fluckiger, U., Moreillon, P., Blaser, J., Bickle, M., Glauser, M.P., Francioli, P. Antimicrob. Agents Chemother. (1994) [Pubmed]
  21. Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides. Archer, G.L., Johnston, J.L. Antimicrob. Agents Chemother. (1983) [Pubmed]
  22. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses. Xiong, Y.Q., Kupferwasser, L.I., Zack, P.M., Bayer, A.S. Antimicrob. Agents Chemother. (1999) [Pubmed]
  23. Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis. Slungaard, A., Mahoney, J.R. J. Exp. Med. (1991) [Pubmed]
  24. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ribera, E., Gómez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, T., Almirante, B., Ocaña, I., Pahissa, A. Ann. Intern. Med. (1996) [Pubmed]
  25. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Hall, S.A., Brickner, M.E., Willett, D.L., Irani, W.N., Afridi, I., Grayburn, P.A. Circulation (1997) [Pubmed]
  26. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Shiro, H., Meluleni, G., Groll, A., Muller, E., Tosteson, T.D., Goldmann, D.A., Pier, G.B. Circulation (1995) [Pubmed]
  27. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini, Y., Satta, J., Määttä, M., Autio-Harmainen, H. J. Pathol. (2001) [Pubmed]
  28. Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. Honstettre, A., Imbert, G., Ghigo, E., Gouriet, F., Capo, C., Raoult, D., Mege, J.L. J. Infect. Dis. (2003) [Pubmed]
  29. Changes in recommendations about amoxycillin prophylaxis for prevention of endocarditis. British Society for Antimicrobial Chemotherapy Endocarditis Working Party. Littler, W.A., McGowan, D.A., Shanson, D.C. Lancet (1997) [Pubmed]
  30. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. DiNubile, M.J. Ann. Intern. Med. (1994) [Pubmed]
  31. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. Sande, M.A., Brooks-Fournier, R.A., Gerberding, J.L. Am. J. Med. (1987) [Pubmed]
  32. Periannular extension of infective endocarditis. Graupner, C., Vilacosta, I., SanRomán, J., Ronderos, R., Sarriá, C., Fernández, C., Mújica, R., Sanz, O., Sanmartín, J.V., Pinto, A.G. J. Am. Coll. Cardiol. (2002) [Pubmed]
  33. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. Mientjes, G.H., van Ameijden, E.J., van den Hoek, A.J., Coutinho, R.A. AIDS (1992) [Pubmed]
 
WikiGenes - Universities